Garth Nicholas

8.2k total citations
64 papers, 1.2k citations indexed

About

Garth Nicholas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Garth Nicholas has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 14 papers in Genetics. Recurrent topics in Garth Nicholas's work include Lung Cancer Treatments and Mutations (17 papers), Glioma Diagnosis and Treatment (13 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Garth Nicholas is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Glioma Diagnosis and Treatment (13 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Garth Nicholas collaborates with scholars based in Canada, United States and United Kingdom. Garth Nicholas's co-authors include Scott A. Laurie, Wayne S. Kendal, Zvi Ram, Chae‐Yong Kim, Steven A. Toms, G. E. Lobley, C. I. Harris, Paul Wheatley‐Price, Robert M. MacRae and Martin C. Tammemägi and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Garth Nicholas

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garth Nicholas Canada 22 558 432 247 214 159 64 1.2k
Renato V. LaRocca United States 18 341 0.6× 418 1.0× 297 1.2× 421 2.0× 143 0.9× 47 1.4k
Robert Iannone United States 20 312 0.6× 980 2.3× 391 1.6× 299 1.4× 171 1.1× 43 2.1k
Steven Lau United States 19 260 0.5× 287 0.7× 374 1.5× 111 0.5× 119 0.7× 35 1.2k
Josef Pichler Austria 17 379 0.7× 260 0.6× 447 1.8× 576 2.7× 210 1.3× 55 1.2k
Han Kyeom Kim South Korea 22 429 0.8× 391 0.9× 349 1.4× 97 0.5× 142 0.9× 83 1.3k
Gail Walker United States 18 741 1.3× 323 0.7× 374 1.5× 112 0.5× 149 0.9× 50 1.7k
Paola Orlandi Italy 25 271 0.5× 591 1.4× 509 2.1× 109 0.5× 263 1.7× 94 1.7k
Eric Hau Australia 16 385 0.7× 324 0.8× 428 1.7× 188 0.9× 478 3.0× 54 1.3k
N. L. Fox United States 17 249 0.4× 249 0.6× 533 2.2× 233 1.1× 149 0.9× 36 1.5k
Hani Ashamalla United States 17 371 0.7× 276 0.6× 196 0.8× 63 0.3× 125 0.8× 70 1.0k

Countries citing papers authored by Garth Nicholas

Since Specialization
Citations

This map shows the geographic impact of Garth Nicholas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garth Nicholas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garth Nicholas more than expected).

Fields of papers citing papers by Garth Nicholas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garth Nicholas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garth Nicholas. The network helps show where Garth Nicholas may publish in the future.

Co-authorship network of co-authors of Garth Nicholas

This figure shows the co-authorship network connecting the top 25 collaborators of Garth Nicholas. A scholar is included among the top collaborators of Garth Nicholas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garth Nicholas. Garth Nicholas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Britt, Rebecca K., et al.. (2025). Thematic and Scholarly Trajectories in the Journal Health Communication. Health Communication. 41(2). 246–254.
2.
Das, Sunit, Cindy Walker‐Dilks, Garth Nicholas, & Arjun Sahgal. (2025). Executive summary of organizational guidance for the care of patients with central nervous system tumours in Ontario: consensus recommendations. Journal of Neuro-Oncology. 175(1). 419–429. 1 indexed citations
3.
Anagnostou, Valsamo, Cheryl Ho, Garth Nicholas, et al.. (2023). ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nature Medicine. 29(10). 2559–2569. 66 indexed citations
4.
5.
Goffin, John R., Gregory R. Pond, Serge Puksa, et al.. (2020). Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population. BMC Pulmonary Medicine. 20(1). 300–300. 13 indexed citations
6.
Taghizadeh, Niloofar, Alain Tremblay, Sonya Cressman, et al.. (2019). Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort. BMJ Open. 9(1). e024719–e024719. 38 indexed citations
7.
Laurie, Scott A., Shantanu Banerji, Normand Blais, et al.. (2019). Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer. Current Oncology. 26(1). 81–93. 35 indexed citations
8.
Daaboul, Nathalie, Garth Nicholas, & Scott A. Laurie. (2018). Algorithm for the Treatment of Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer: An Evidence-Based Overview. Current Oncology. 25(11). 77–85. 9 indexed citations
9.
Al-Baimani, Khalid, et al.. (2018). Are Clinical Trial Eligibility Criteria an Accurate Reflection of a Real-World Population of Advanced Non-Small-Cell Lung Cancer Patients?. Current Oncology. 25(4). 291–297. 34 indexed citations
10.
Clemons, Mark, Sasha Mazzarello, Gregory R. Pond, et al.. (2018). A prospective intervention to improve happiness and reduce burnout in oncologists. Supportive Care in Cancer. 27(4). 1563–1572. 7 indexed citations
11.
Zhang, Tinghua, et al.. (2017). The influence of season and distance to a cancer centre on lung cancer treatment rates. Cancer Treatment and Research Communications. 12. 25–31. 1 indexed citations
12.
Valdés, Mario J., Garth Nicholas, Shailendra Verma, & Timothy R. Asmis. (2017). Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors. Case Reports in Oncology. 10(2). 462–472. 16 indexed citations
13.
Haaf, Kevin ten, Martin C. Tammemägi, Susan J. Bondy, et al.. (2017). Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada. PLoS Medicine. 14(2). e1002225–e1002225. 96 indexed citations
14.
Goffin, John R., Gregory R. Pond, Alain Tremblay, et al.. (2017). Use of a marketing plan for recruitment to a lung cancer screening study.. Journal of Clinical Oncology. 35(15_suppl). 1548–1548. 1 indexed citations
15.
Brule, Stephanie Yasmin, Khalid Al-Baimani, Tinghua Zhang, et al.. (2016). Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not. Lung Cancer. 97. 15–21. 39 indexed citations
16.
Bossé, Dominick, Esmeralda Celia Marginean, D. Blair Macdonald, Garth Nicholas, & Shailendra Verma. (2016). Tumour Lysis Syndrome in Solid Tumours Associated with Tyrosine Kinase Inhibitors – A Case Illustrated Review. European Oncology & Haematology. 12(1). 51–51.
17.
Laurie, Scott A., Glenwood D. Goss, Frances A. Shepherd, et al.. (2013). A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium. Clinical Lung Cancer. 15(1). 52–57. 29 indexed citations
18.
Nicholas, Garth. (2013). Metaphors and Malignancy: Making Sense of Cancer. Current Oncology. 20(6). 608–609. 3 indexed citations
19.
Natale, Ronald B., Garth Nicholas, Frank A. Greco, et al.. (2007). PD3-1-8: Motexafin Gadolinium (MGd) is active as a single agent in advanced non-small-cell lung cancer (NSCLC) patients who failed platinum-based chemotherapy: preliminary results of a phase II trial. Journal of Thoracic Oncology. 2(8). S462–S462. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renato V. LaRocca Breakdown of academic impact, for papers by Robert Iannone Breakdown of academic impact, for papers by Steven Lau Breakdown of academic impact, for papers by Josef Pichler Breakdown of academic impact, for papers by Han Kyeom Kim Breakdown of academic impact, for papers by Gail Walker Breakdown of academic impact, for papers by Paola Orlandi Breakdown of academic impact, for papers by Eric Hau Breakdown of academic impact, for papers by N. L. Fox Breakdown of academic impact, for papers by Hani Ashamalla
Rankless by CCL
2026